As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.
By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...
Carrying excess body weight has become a prevalent problem, affecting people's lives in ways that extend beyond physical appearance. It frequently makes people feel stuck, impacting their self-esteem, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results